NO20055830L - Proglitazpnsalter, sa som pioglitazonsulfat og farmasoytiske sammensetnnger og fremgangsmater ved bruk av de samme - Google Patents

Proglitazpnsalter, sa som pioglitazonsulfat og farmasoytiske sammensetnnger og fremgangsmater ved bruk av de samme

Info

Publication number
NO20055830L
NO20055830L NO20055830A NO20055830A NO20055830L NO 20055830 L NO20055830 L NO 20055830L NO 20055830 A NO20055830 A NO 20055830A NO 20055830 A NO20055830 A NO 20055830A NO 20055830 L NO20055830 L NO 20055830L
Authority
NO
Norway
Prior art keywords
salts
proglitazone
methods
same
pharmaceutical compositions
Prior art date
Application number
NO20055830A
Other languages
English (en)
Other versions
NO20055830D0 (no
Inventor
Jie Zhu
Frantisek Picha
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of NO20055830D0 publication Critical patent/NO20055830D0/no
Publication of NO20055830L publication Critical patent/NO20055830L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Vannløsehge salter av pioglitazon, spesielt pioglitazon-sulfat, er nyttige i farmasøytiske anvendelser.
NO20055830A 2003-05-13 2005-12-08 Proglitazpnsalter, sa som pioglitazonsulfat og farmasoytiske sammensetnnger og fremgangsmater ved bruk av de samme NO20055830L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46983803P 2003-05-13 2003-05-13
PCT/EP2004/005133 WO2004101561A1 (en) 2003-05-13 2004-05-13 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same

Publications (2)

Publication Number Publication Date
NO20055830D0 NO20055830D0 (no) 2005-12-08
NO20055830L true NO20055830L (no) 2005-12-08

Family

ID=33452331

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055830A NO20055830L (no) 2003-05-13 2005-12-08 Proglitazpnsalter, sa som pioglitazonsulfat og farmasoytiske sammensetnnger og fremgangsmater ved bruk av de samme

Country Status (12)

Country Link
US (2) US7230016B2 (no)
EP (1) EP1622899B1 (no)
JP (1) JP2006528948A (no)
AT (1) ATE366733T1 (no)
AU (1) AU2004238537A1 (no)
CA (1) CA2525316A1 (no)
DE (1) DE602004007505T2 (no)
ES (1) ES2290709T3 (no)
IL (1) IL171875A0 (no)
NO (1) NO20055830L (no)
WO (1) WO2004101561A1 (no)
ZA (1) ZA200509155B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7230016B2 (en) * 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
WO2005080387A2 (en) * 2004-02-20 2005-09-01 Synthon B.V. Processes for making pioglitazone and compounds of the processes
JP2008195625A (ja) * 2007-02-08 2008-08-28 Pharma Frontier Kk Ｇ蛋白質共役型レセプター抑制剤および医薬
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
NZ597381A (en) 2007-09-14 2013-03-28 Metabolic Solutions Dev Co Llc Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases
JP2011506279A (ja) * 2007-12-08 2011-03-03 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 経口で分散可能な錠剤
JP5383123B2 (ja) * 2008-09-02 2014-01-08 株式会社トクヤマ ピオグリタゾン塩酸塩の製造方法
US20100060985A1 (en) 2008-09-09 2010-03-11 Fujifilm Corporation Method for producing polarizing plate, and automobile's windshield
WO2010136847A1 (en) * 2009-05-26 2010-12-02 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Coated metformin with pioglitazone solution
KR20120092712A (ko) * 2009-12-15 2012-08-21 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 진성 당뇨병 및 다른 대사성 질환의 치료를 위한 ｐｐａｒ 절약형 티아졸리딘디온 및 복합제
HUE038042T2 (hu) * 2009-12-15 2018-09-28 Cirius Therapeutics Inc PPAR helyettesítõ tiazolidindion sók metabolikus betegségek kezelésére
WO2012153312A1 (en) 2011-05-11 2012-11-15 Ranbaxy Laboratories Limited Process for the purification of pioglitazone
MX2015003700A (es) * 2012-09-21 2015-10-30 Reoxcyn Discoveries Group Inc Celda para electrolizar un liquido.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
AR240698A1 (es) 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
FI91869C (fi) 1987-03-18 1994-08-25 Tanabe Seiyaku Co Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
ATE123278T1 (de) 1991-03-25 1995-06-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von ethern.
JPH07138258A (ja) * 1993-11-16 1995-05-30 Taiho Yakuhin Kogyo Kk チアゾリジンジオン誘導体又はその塩
DE69530094T2 (de) * 1994-08-10 2004-01-29 Takeda Chemical Industries Ltd Thiazolidindione derivate, ihre herstellung und verwendung
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5814647A (en) * 1997-03-04 1998-09-29 Board Of Regents, The University Of Texas System Use of troglitazone and related compounds for the treatment of the climacteric symptoms
SE9702305D0 (sv) * 1997-06-17 1997-06-17 Astra Ab New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.
AU2002311057A1 (en) 2001-04-26 2002-11-11 Leciva, A.S. Method for obtaining pioglitazone as an antidiabetic agent
US7230016B2 (en) * 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
US20050059708A1 (en) * 2003-05-13 2005-03-17 Karel Pospisilik Processes for making thiazolidinedione derivatives and compounds thereof

Also Published As

Publication number Publication date
NO20055830D0 (no) 2005-12-08
DE602004007505D1 (de) 2007-08-23
ZA200509155B (en) 2007-04-25
ES2290709T3 (es) 2008-02-16
JP2006528948A (ja) 2006-12-28
US20070203199A1 (en) 2007-08-30
CA2525316A1 (en) 2004-11-25
EP1622899B1 (en) 2007-07-11
ATE366733T1 (de) 2007-08-15
IL171875A0 (en) 2006-04-10
US20050054684A1 (en) 2005-03-10
US7230016B2 (en) 2007-06-12
AU2004238537A1 (en) 2004-11-25
EP1622899A1 (en) 2006-02-08
DE602004007505T2 (de) 2008-03-13
WO2004101561A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
IS7543A (is) Bensóþíadíasepínafleiður, aðferðir til framleiðslu þeirra og lyfjablöndur sem innihalda þær
SE0100901D0 (sv) New composition
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
NO20065355L (no) Materialer som inneholoder en hul glucanpartikkel eller en celleveggkomponent som innkapsler en terpenkomponen, samt fremgangsmater for anvendelse av samme
ITPD20020138A1 (it) Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
ATE407967T1 (de) Nukleierungsmittel
LTPA2018502I1 (lt) Per burną vartojamos kladribino kompozicijos
NO2014009I2 (no) Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser
ATE376996T1 (de) Antibakterielle mittel
MY138285A (en) Fab i inhibitors
NO20083147L (no) Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
NO20054905D0 (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
WO2006083936A3 (en) Anti-ephb2 antibodies and methods using same
NO20055830D0 (no) Proglitazpnsalter, sa som pioglitazonsulfat og farmasoytiske sammensetnnger og fremgangsmater ved bruk av de samme
DK1670769T3 (da) Benzimidazol-derivater, sammensætninger indeholdende disse, fremstilling deraf og anvendelser deraf
NO20075140L (no) Fremgangsmater og preparater for modulering av vaskulaer integritet
NO20062605L (no) Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper
EP1670894B8 (en) Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
NO20073071L (no) Benzotiazolformuleringer og anvendelse av disse
SE0300457D0 (sv) Novel compounds
EP1711490A4 (en) NEW P-GLYCOPROTEIN INHIBITOR, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
WO2005094761A8 (en) Hair treatment compositions comprising a disaccharide, a di-acid and a source of ammonium ions
ATE391489T1 (de) Haarbehandlungszusammensetzungen